Table 83.
Reported confirmed human cases of tularaemia and notification rates per 100,000 population in EU MSs and non‐MS countries, by country and by year, 2017–2021
| Country | 2021 | 2020 | 2019 | 2018 | 2017 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| National coverage (a) | Data format (a) | Confirmed cases and rates | Confirmed cases and rates | Confirmed cases and rates | Confirmed cases and rates | Confirmed cases and rates | ||||||
| Cases | Rate | Cases | Rate | Cases | Rate | Cases | Rate | Cases | Rate | |||
| Austria | Y | C | 58 | 0.65 | 33 | 0.37 | 20 | 0.23 | 7 | 0.08 | 13 | 0.15 |
| Belgium | Y | A | 7 | 0.06 | 1 | 0.01 | 4 | 0.03 | 0 | 0 | 5 | 0.04 |
| Bulgaria | Y | A | 0 | 0 | 2 | 0.03 | 1 | 0.01 | 1 | 0.01 | 1 | 0.01 |
| Croatia | Y | C | 0 | 0 | 0 | 0 | 1 | 0.02 | 0 | 0 | 3 | 0.07 |
| Cyprus | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Czechia | Y | C | 50 | 0.47 | 67 | 0.63 | 102 | 0.96 | 32 | 0.30 | 51 | 0.48 |
| Denmark (b) | – | – | – | – | – | – | – | – | – | – | – | – |
| Estonia | Y | C | 1 | 0.08 | 1 | 0.08 | 2 | 0.15 | 1 | 0.08 | 0 | 0 |
| Finland | Y | C | 86 | 1.6 | 143 | 2.6 | 48 | 0.87 | 7 | 0.13 | 32 | 0.58 |
| France | Y | C | 143 | 0.21 | 45 | 0.07 | 45 | 0.07 | 11 | 0.02 | 19 | 0.03 |
| Germany | Y | C | 113 | 0.14 | 59 | 0.07 | 70 | 0.08 | 52 | 0.06 | 52 | 0.06 |
| Greece | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hungary | Y | C | 7 | 0.07 | 20 | 0.20 | 22 | 0.23 | 17 | 0.17 | 11 | 0.11 |
| Ireland | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Italy | Y | C | 3 | 0.01 | 0 | 0 | 1 | < 0.01 | 0 | 0 | 2 | < 0.01 |
| Latvia | Y | C | 0 | 0 | 0 | 0 | 2 | 0.10 | 0 | 0 | 0 | 0 |
| Lithuania | Y | C | 7 | 0.25 | 2 | 0.07 | 4 | 0.14 | 5 | 0.18 | 5 | 0.18 |
| Luxembourg | Y | C | 3 | 0.47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Malta | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netherlands | Y | C | 5 | 0.03 | 1 | 0.01 | 3 | 0.02 | 2 | 0.01 | 1 | 0.01 |
| Poland | Y | C | 43 | 0.11 | 5 | 0.01 | 21 | 0.06 | 16 | 0.04 | 30 | 0.08 |
| Portugal | Y | C | 0 | 0 | 1 | 0.01 | 1 | 0.01 | 2 | 0.02 | 0 | 0 |
| Romania | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Slovakia | Y | C | 0 | 0 | 12 | 0.22 | 20 | 0.37 | 6 | 0.11 | 2 | 0.04 |
| Slovenia | Y | C | 54 | 2.6 | 1 | 0.05 | 7 | 0.34 | 4 | 0.19 | 1 | 0.05 |
| Spain | Y | C | 4 | 0.01 | 1 | < 0.01 | 88 | 0.19 | 4 | 0.01 | 11 | 0.02 |
| Sweden | Y | C | 292 | 2.8 | 247 | 2.4 | 817 | 8.0 | 102 | 1.0 | 84 | 0.84 |
| EU Total 27 | – | – | 876 | 0.20 | 641 | 0.15 | 1,279 | 0.29 | 269 | 0.06 | 323 | 0.07 |
| United Kingdom | – | – | – | – | – | – | 0 | 0 | 1 | < 0.01 | 0 | 0 |
| EU Total (c) | – | – | 876 | 0.20 | 641 | 0.15 | 1,279 | 0.25 | 270 | 0.05 | 323 | 0.06 |
| Iceland | Y | C | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Norway | Y | C | 95 | 1.8 | 99 | 1.8 | 183 | 3.4 | 58 | 1.1 | 92 | 1.7 |
| Liechtenstein | Y | C | 1 | 2.6 | 133 | 1.5 | 154 | 1.8 | 117 | 1.4 | 152 | 1.8 |
| Switzerland (d) | Y | C | 212 | 2.4 | ||||||||
–: Data not reported.
(a)
: Y: yes; N: no; A: aggregated data; C: case‐based data.
(b)
: No surveillance system.
(c)
: Cases reported by the United Kingdom for the period 2017–2019 were also considered for this estimation (EU‐28). When the United Kingdom data were collected for the period 2017–2019, the United Kingdom was an EU MS, but it became a third country on 1 February 2020.
(d)
: Switzerland provided data directly to EFSA. The human data for Switzerland include data from Liechtenstein for the years 2017–2020.